Weight Loss News and Research RSS Feed - Weight Loss News and Research

Aptensio XR once-daily treatment for ADHD to be available in Summer 2015

Aptensio XR once-daily treatment for ADHD to be available in Summer 2015

Today, Rhodes Pharmaceuticals L.P. announced that Aptensio XR, a once-daily central nervous system stimulant indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) will be available to patients beginning Summer 2015. [More]
GHIT Fund expands investments in leishmaniasis, diagnostic tests

GHIT Fund expands investments in leishmaniasis, diagnostic tests

The Global Health Innovative Technology Fund, which in the last two years has funded almost $32 million for innovative tools to tackle global infectious diseases, today announced additional investments of nearly $11 million that bring its portfolio to approximately $43 million. [More]
Splicing pattern of obesity, type 2 diabetes genes may contribute to pathophysiology of obesity

Splicing pattern of obesity, type 2 diabetes genes may contribute to pathophysiology of obesity

Alternative splicing of obesity and type 2 diabetes related genes may contribute to the pathophysiology of obesity, according to research from the University of Eastern Finland. Obesity leads to changes in the splicing pattern of metabolically relevant genes such as TCF7L2 and INSR, resulting in impaired insulin action. [More]
Weight loss can improve outcomes in lung transplant patients

Weight loss can improve outcomes in lung transplant patients

Obesity is a complicating factor for many surgical patients. In a recent study published in the Journal of Heart and Lung Transplantation, Mayo Clinic researchers have shown that losing weight can have a positive impact on outcomes for lung transplant patients. [More]
UCB sponsoring several presentations on Cimzia for Crohn's disease at DDW 2015

UCB sponsoring several presentations on Cimzia for Crohn's disease at DDW 2015

UCB, a global biopharmaceutical company focusing on immunology and neurology treatment and research, is sponsoring several data presentations on Cimzia (certolizumab pegol) at Digestive Disease Week 2015, taking place in Washington, DC from May 16-19. [More]
Obesity rates elevated in childhood cancer survivors who are exposed to certain treatments

Obesity rates elevated in childhood cancer survivors who are exposed to certain treatments

Individuals who had cancer as a child may be at increased risk of being obese due to the therapies they received during their youth. The finding comes from a new study published early online in CANCER, a peer-reviewed journal of the American Cancer Society. The study's results suggest the need for effective counseling and weight loss interventions for certain childhood cancer survivors. [More]
Orexigen Therapeutics provides update on business and financial results for Q1 2015

Orexigen Therapeutics provides update on business and financial results for Q1 2015

Orexigen Therapeutics, Inc. today announced business and financial results for the first quarter ended March 31, 2015. [More]
Mouth and tongue exercises can significantly reduce snoring frequency

Mouth and tongue exercises can significantly reduce snoring frequency

A Google search using the key words "snoring" and "treatment" yielded over 5 million results, but no standard treatment is available for primary snoring or snoring associated with a mild form of obstructive sleep apnea (OSA). [More]
Obesity and depression play role in excessive daytime sleepiness

Obesity and depression play role in excessive daytime sleepiness

Obesity and depression -- not only lack of sleep -- are underlying causes for regular drowsiness, according to Penn State College of Medicine researchers. They say these findings could lead to more personalized sleep medicine for those with excessive daytime sleepiness (EDS). [More]
SLU study explores benefits of exercise and diet in managing Type 2 diabetes risk

SLU study explores benefits of exercise and diet in managing Type 2 diabetes risk

In a paper recently published in Diabetes Care, Saint Louis University associate professor of nutrition and dietetics Edward Weiss, Ph.D, and colleagues found that, though people often think of the benefits from exercise, calorie restriction and weight loss as interchangeable, it appears that they may all offer distinct and cumulative benefits when it comes to managing Type 2 diabetes risk. [More]
Study explores non-biological factors that may cause fewer men to seek bariatric surgery

Study explores non-biological factors that may cause fewer men to seek bariatric surgery

A new study by researchers at the University of California, San Diego School of Medicine has identified demographic, socioeconomic and cultural factors that contribute to a major gender disparity among U.S. men and women undergoing weight loss surgeries. Men undergo the surgeries in far lower numbers than women. [More]
Adjustable gastric band surgery, weight management program offer similar benefits in diabetes patients

Adjustable gastric band surgery, weight management program offer similar benefits in diabetes patients

Weight loss is never easy, but it's important for overweight people with type 2 diabetes seeking to control their blood sugar levels and optimize their health. A small clinical trial among such patients led by Joslin Diabetes Center and Brigham and Women's Hospital researchers now has shown that two approaches--adjustable gastric band surgery and an intensive group-based medical diabetes and weight management program--achieved similar improvements in controlling blood sugar levels after one year. [More]
Teen-LABS research study reveals musculoskeletal disease outcomes among obese adolescents

Teen-LABS research study reveals musculoskeletal disease outcomes among obese adolescents

Outcomes regarding musculoskeletal disease among severely obese adolescents participating in the "Teen Longitudinal Assessment of Bariatric Surgery" (Teen-LABS) study were published this week in JAMA Pediatrics. Teen-LABS is a multi-center clinical study funded by the National Institute of Diabetes and Digestive and Kidney Diseases at the National Institutes of Health that is examining the safety and health effects of surgical weight loss procedures. [More]
Health food stores promote adult-only dietary supplements to minors

Health food stores promote adult-only dietary supplements to minors

Fifteen year olds are not only able to buy over-the-counter dietary supplements from a sampling of health food stores across the country, the staff at those stores actually went so far as to recommend certain products, despite labels reading "for adult use only." [More]
Research highlights value of serological testing for Coeliac disease in anyone with symptoms

Research highlights value of serological testing for Coeliac disease in anyone with symptoms

Coeliac disease is one of the most common life-long conditions in Europe, yet many people remain undiagnosed and lengthy diagnostic delays may be putting lives at risk. Today, doctors are being urged to consider testing for Coeliac disease in anyone showing signs and symptoms of the condition and to consider screening everyone in high-risk groups. [More]
Remogliflozin etabonate: A potential treatment option for management of NASH and NAFLD

Remogliflozin etabonate: A potential treatment option for management of NASH and NAFLD

Data presented today at The International Liver Congress 2015 demonstrates that remogliflozin etabonate, an investigational drug in type 2 diabetes, is a potential treatment option for the management of patients with non-alcoholic steatohepatitis (NASH) and non-alcoholic fatty liver disease (NAFLD). [More]
Miriam Hospital awarded BDC designation for bariatric surgery

Miriam Hospital awarded BDC designation for bariatric surgery

Blue Cross Blue Shield of Rhode Island has awarded The Miriam Hospital a Blue Distinction Center+ (BDC) designation for bariatric surgery. A designation by the Blue Distinction Centers for Specialty Care program, BDCs are nationally designated health care facilities that deliver quality specialty care based on objective measures for patient safety and better health outcomes. [More]
Upsher-Smith presents favorable data from PREVAIL OLE study of Qudexy XR capsules

Upsher-Smith presents favorable data from PREVAIL OLE study of Qudexy XR capsules

Upsher-Smith Laboratories, Inc. presented data from a 52-week, open-label extension study (PREVAIL OLE) showing that Qudexy XR (topiramate) extended-release capsules offered a long-term adjunctive treatment option with a favorable tolerability profile for a high proportion of patients with refractory partial-onset seizures (POS). [More]

New project to tackle escalating problem of frailty among ageing population in Europe

A 2.3m euros project to tackle the escalating problem of frailty among Europe's ageing population will be conducted by an international team of researchers. [More]
Incidence of esophageal cancer linked to GERD rises six-fold in recent decades

Incidence of esophageal cancer linked to GERD rises six-fold in recent decades

Esophageal cancer is one of the fastest-growing and deadliest cancers in the U.S. According to the American Cancer Society, an estimated 17,000 new cases of esophageal cancer will be diagnosed in 2015. Incidence of adenocarcinoma, a type of esophageal cancer linked to GERD (gastroesophageal reflux disease) has risen six-fold in recent decades. [More]
Advertisement
Advertisement